athenahealth (athenahealth) ROCE % : 11.39% (As of Sep. 2018)

View and export this data going back to 2007. Start your Free Trial

What is athenahealth ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. athenahealth's annualized ROCE % for the quarter that ended in Sep. 2018 was 11.39%.

athenahealth ROCE % Historical Data

The historical data trend for athenahealth's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

athenahealth ROCE % Chart

athenahealth Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

ROCE %

Get a 7-Day Free Trial

1.22

0.13

2.98

2.81

6.61

athenahealth Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
ROCE %	Get a 7-Day Free Trial															6.91	13.75	14.06	13.32	11.39

athenahealth ROCE % Calculation

athenahealth's annualized ROCE % for the fiscal year that ended in Dec. 2017 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2017 )		(A: Dec. 2016 )		(A: Dec. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2017 )		(A: Dec. 2016 )		(A: Dec. 2017 )
	=	69.9	/	( ( (1189.2 - 197.9)	+	(1332.3 - 207.7) )	/ 2 )
	=	69.9	/	( (991.3	+	1124.6)	/ 2 )
	=	69.9	/	1057.95
	=	6.61 %

athenahealth's ROCE % of for the quarter that ended in Sep. 2018 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2018 )		(Q: Jun. 2018 )		(Q: Sep. 2018 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2018 )		(Q: Jun. 2018 )		(Q: Sep. 2018 )
	=	152.8	/	( ( (1526.4 - 209)	+	(1589 - 224) )	/ 2 )
	=	152.8	/	( ( 1317.4	+	1365 )	/ 2 )
	=	152.8	/	1341.2
	=	11.39 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2018) EBIT data.

athenahealth (NAS:ATHN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

athenahealth ROCE % Related Terms

Thank you for viewing the detailed overview of athenahealth's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

athenahealth (athenahealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.athenahealth.com

Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.

Executives

Brian P Mckeon	director	IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane	director	C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria	director	C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park	director	311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull	director	221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak	director	P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt	director, other: Executive Chairman	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine	officer: Chief Financial Officer	C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy	director	311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus	officer: EVP and CFAO	C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein	officer: SVP, GC, and Secretary	311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky	officer: SVP, Chief Product Officer	C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams	officer: CFO & SVP	311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts	director	C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025